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Abstract 
Introduction: Preoperative staging is the main prognostic factor and is crucial in therapeutic selection of 
esophageal cancer.  
Aim: Evaluate computerized tomography and endoscopic ultrasonography accuracy in preoperative 
esophageal cancer staging. 
Methods: A retrospective study between 1/1/2010 and 30/9/2015 was performed. Sensibility, specificity, 
positive and negative predictive values, and accuracy for T and N stage was calculated. Using the Cohen 
weighted K, the degree of concordance between the exams and anatomopathological results was assessed.  
Results: Computerized tomography and endoscopic ultrasonography presented an accuracy of 35.7% 
(95%CI, 17.9-53.4) and 64.3% (95%CI, 46.5-82) for T, and 57.1% (95%CI, 38.8-75.4) and 71.4% (95%CI, 
54.6-88.1) for N. 
Computerized tomography presented an sensibility, specificity, positive and negative predictive values of 
12.5%(95%CI, 0.32-52.6), 85%(95%CI, 62.1-96.8), 25%(95%CI, 0.63-80.6), 70.8%(95%CI, 48.9-87.4) for 
T1; 33.3%(95%CI, 4.3-77.7), 68.2%(95%CI, 45.1-86.1), 22.2%(95%CI, 2.8-60), 78.9%(95%CI, 54.4-93.9) 
for T2; 50%(95%CI, 23-77), 57.1%(95%CI, 28.9-82.3), 53.8%(95%CI, 25.1-80.8), 53.3%(95%CI, 26.6-78.1) 
for T3; 30%(95%CI, 6.67-65.25), 72.2%(95%CI, 46.5-90.3), 37.5%(95%CI, 8.5-75.5), 65%(95%CI, 40.8-
84.6) for N. For endoscopic ultrasonography: 62.5%(95%CI, 0-40.96), 95%(95%CI, 75.1-99.9), 
83.3%(95%CI, 35.9-99.6), 86.4%(95%CI, 65.1-97.1) for T1; 50%(95%CI, 11.8-88.2), 77.3%(95%CI, 54.6-
92.2), 37.5%(95%CI, 8.5-75.6), 85%(95%CI, 62.1-96.8) for T2; 71.4%(95%CI, 41.9-91.6), 71.4%(95%CI, 
41.9-91.6), 71.4%(95%CI, 41.9-91.6), 71.4%(95%CI, 41.9-91.6) for T3; 90%(95%CI, 55.5-99.7), 
61.1%(95CI, 35.7-82.7), 56.2%(95%CI, 29.9-80.2), 92%(95%CI, 62.5-99.8) for N. 
Concordance was poor for computerized tomography and moderate for endoscopic ultrasonography. 
Conclusions: Endoscopic ultrasonography has a better accuracy in esophageal cancer staging, for T and N, 
showing a high sensibility, specificity, positive and negative predictive values, with a better accuracy for T3. 
Only endoscopic ultrasonography showed a significant relationship with an atom pathological results 
(p<0.05). 
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1. INTRODUCTION 
According to the latest report from the World 
Health Organization (WHO), the oncologic 
diseases incidence rate, presents a concerning 
rising trend.  In 2012, the incidence was almost 
14 million, and an increase of 22 million per 
year is expected over the next two decades.
1
 
This disturbing increase includes the esophageal 
cancer (EC), which is in eighth place in the list 
of most frequent cancers worldwide, and in 
sixth place regarding mortality.
2
 In 2012, 
approximately 456 1000 new diagnoses (3.2% 
of the total) of EC were carried out, and 
approximately 400 1000 deaths (4.9% of the 
total) were attribute to it
1
, and this number is 
expected to grow 140% by 2025.
3
 
There are essentially two histological types of 
EC, adenocarcinoma and squamous cell 
carcinoma (SCC). Despite the last one being the 
more common worldwide, there was a marked 
increase in the incidence of adenocarcinoma in 
the last two decades.
4,5
  
Currently, at the time of diagnosis, 50% of 
patients already present metastatic disease, 
about 30% have locally advanced disease and 
less than 20% present an initial staging, 
compatible with curative treatment.
6
 
Corporately, the factor with the greatest impact 
on the prognosis, as well as in the selection of 
therapeutics, is the preoperative staging.
 4,5,7
  
Several imaging modalities can be used for 
preoperative staging, namely Computerized 
Tomography (CT), Magnetic Resonance 
Imaging (MRI), Positron Emission Tomography 
(PET) and esophageal Endoscopic Ultrasound 
(EUS).
5
 The information obtained from these 
tests is then grouped according to the 
classification system Tumour-Node-Metastasis 
(TNM) of the American Joint Committee on 
Cancer.
8
 
At the Braga Hospital (BH), the exams used for 
EC staging are thoracic CT and EUS, so it 
becomes pertinent to assess the accuracy of 
these exams, comparing it with the 
histopathological result of the surgical 
specimen. 
2. METHODS 
The study population included patients with 
histological diagnosis of CE treated in the 
Esophagogastric Unit of BH, between January 
1
st
, 2010 and September 30
th
, 2015.  
2.1. Inclusion criteria: 
For this study were: patients with histological 
diagnosis of esophageal adenocarcinoma and 
CCE of the esophagus; patients with a 
conclusive preoperative staging by CT and EUS 
and patients with pathology staging results 
based on the surgical specimen.  
2.2. Exclusion criteria where the following 
Patients with histological diagnosis differing 
from the above; patients who did not undergo 
CT, EUS or for whom these tests were 
inconclusive; patients not submitted to surgical 
treatment or submitted to palliative surgery with 
and patients without results from pathology 
staging. 
A convenience sample of 28 patients who meet 
the previously defined criteria, was studied. 
Clinical and staging data collected include: age, 
gender, tumour location, adjuvant therapeutic 
and T/N staging by CT and EUS. Pathological 
data comprise the histological type, T/N staging, 
and lymphatic and venous invasion. 
The collected data were organized in an Excel 
(Microsoft Office 2010) database, and the 
Statistical Package for Social Sciences (SPSS) 
version 24.0 was used. 
A descriptive analysis of the variables under 
study was performed, providing frequencies, 
means (M) and standard deviations (SD). 
Sensitivity, specificity, positive and negative 
predictive values (PV) of CT and EUS staging, 
related to T and N, were compared with 
pathology results. For this purpose, the online 
tool MedCalc, available in http://www.medcalc. 
org/calc/diagnostic_test.php was used. Efficacy 
was calculated by the formula (TP+TN/n) and 
the confidence interval (CI) by the formula P-
Z×√P(1-P)/ √n; P+Z×√P(1-P)/ √n. 
The agreement between the staging results 
obtained by CT and EUS with anatomo- 
pathological study was assessed by calculating 
the value of Cohens’s Kappa (Kw); for this 
purpose, the online tool VassarStats, available in 
http://vassarstats.net/kappa.html. Value of Kw 
between 0.00-0.20 indicates poor agreement; 
between 0.21-0.40 points to a considerable 
agreement; between 0.41-0.60, reveals a 
moderate agreement; between 0.61-0.80 
indicates a good agreement; and between 0.81-
1.00 shows an excellent agreement.
9
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For all testes, it was assumed a significance of 
0.05 and a confidence interval (CI) of 95%. 
This project was approved by HB’s Ethics 
Committee and also by Ethics Subcommittee for 
Life and Health Sciences. 
3. RESULTS 
3.1. Patient’s Data 
The casuistic included 28 patients, 68% (n=19) 
males and 32% (n=9) females, aged between 40 
and 85 years (M=65; SD=12). 10.7% (n=3) of 
the tumours, were located in the esophagus 
upper third, 21.6% (n=6) in the middle third and 
67.9% (n=19) in the lower third of the 
esophagus. Lower third of esophagus was the 
most common localization in both genders, 
77.8% and 63% on female and male gender, 
respectively. 
According to pathological analyse, 39.3% 
(n=11) of tumours was adenocarcinomas and 
60.7% (n=17) was CCE. Vascular venous 
invasion was present in 32.1% (n=9) of patients, 
and lymphatic invasion in 17.9% (n=5).  
Of the 28 patients, 10.7% (n=3) and 3.6 % (n=1) 
performed, respectively, chemotherapy and 
radiotherapy as adjuvant therapeutic. 
Follow-up data demonstrate 37.5% (n=10) 
deaths. 
3.2. T and N Staging  
Regarding T staging by CT, 14.3% (n=4); 
32.1% (n=9); 46.4% (n=13) and 7.1% (n=2) was 
staged as T1, T2, T3 and T4, respectively. With 
respect to N staging, by CT, 71.4% (n=20) of 
the cases, do not have lymph node involvement 
(N0), and 28.6% (n=8) have lymph node 
involvement (N+). 
When staging was accomplished by EUS, 
21.4% (n=6); 28.6% (n=8) and 50% (n=14) was 
staged as T1, T2 and T3, 42.9% (n=12) as N0 
and 57.1% (n=16) as N+.  
According to pathological results 28.6% (n=8); 
21.4% (n=6) and 50% (n=14) was staged as T1, 
T2 and T3; 64.3% (n=18) as N0 and 35.7% 
(n=10) as N+. 
3.3. Comparison between CT and an atomopa 
-thological Staging 
Comparing CT staging versus anatom -
opathological results based on surgical 
specimen, we noted a substaging in 10.7% of 
cases (n=3) staged as T1 and in 14.3% (n=4) 
staged as T2 by CT; an overstaging was 
observed in 10.7% (n=3) of the cases staged as 
T2 and in 21.4% (n=6) staged as T3. We also 
observed that all the cases classified as T4 by 
CT was overstaged (7.1%, n=2). 
According to N staging, obtained by CT and by 
anatomopathological results, a substaging was 
noted in 25% (n=7) of the cases staged as N0, 
and an overstaging was noted in 17.8% (n=5) of 
the cases staged as N+ by CT. 
The sensitivity of CT in pre-operative staging of 
EC was calculated, and it was 12.5% (95% CI, 
0.32-52.6) for T1, 33.3% (95% CI, 4.3-77.7) for 
T2 and 50% (95% CI, 23-77) for T3. As for 
specificity, this parameter is 85% (95% CI, 
62.1-96.8) for T1, 68.2% (95% CI, 45.1-86.1) 
for T2 and 57.1% (95% CI, 28.9-82.3) for T3. 
In relation to efficacy, CT shows efficacy of 
35.7% (95%CI, 17.9-53.4) for T staging, 64.3% 
(95% CI, 46.5-82) in particular for T1 staging, 
60.7% (95% CI, 42.6-78.8) for T2 staging and 
53.6% (95% CI, 35.1-72) for T3 staging. 
According to N staging, the sensitivity, 
specificity and efficacy in preoperative staging 
was 30% (95% CI, 6.67-65.25), 72.2% (95% CI, 
46.5-90.3) and 57.1% (95% CI, 38.8-75.4), 
respectively. 
In order to determine the correlation between 
CT versus anatomopathological staging, Kw 
was calculated. Kw was 0.11 (95%CI, 0-0.36) 
For T staging and 0.02 (95%CI, 0-0.44) for N 
staging. 
3.4. Comparison between EUS and anatomo -
-pathological Staging 
Comparing EUS staging versus 
anatomopathological results based on surgical 
specimen, we noted a substaging in 3.6% of 
cases (n=1) staged as T1 and in 10.7% (n=3) 
staged as T2 by EUS; an overstaging was 
observed in 7.1% (n=2) of the cases staged as 
T2 and in 14.3% (n=4) staged as T3.  
According to N staging, obtained by EUS and 
by anatomopathological results, a substaging 
was noted in 3.6% (n=1) of the cases staged as 
N0, and an overstaging was noted in 25% (n=7) 
of the cases staged as N+ by EUS. 
The sensitivity of EUS in pre-operative staging 
of EC was calculated, and it was 62.5% (95% 
CI, 0-40.96) for T1, 50% (95% CI, 11.8-88.2) 
for T2 and 71.4% (95% CI, 41.9-91.6) for T3. 
As for specificity, this parameter is 95% (95% 
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CI, 75.1-99.9) for T1, 77.3% (95% CI, 54.6-
92.2) for T2 and 71.4% (95% CI, 41.9-91.6) for 
T3. 
In relation to efficacy, EUS shows efficacy of 
64.3% (95%CI, 46.5 -82) for T staging, 85.7% 
(95% CI, 72.7-98.7) in particular for T1 staging 
and 71.4% (95% CI, 54.7-88.1) for T2 and T3 
staging. 
4. DISCUSSION 
Currently therapeutic approach of EC is 
multidisciplinary and individualized. Therefore, 
a correct preoperative staging is essential to the 
selection of the best therapeutic option, with a 
clear impact on the patient's prognosis.
5,7
  
From the various methods available for 
preoperative staging, CT and EUS, are the most 
commonly used.
10
 Despite, literature results are 
not consensual, EUS seems to present a better 
definition for T staging when compared with the 
CT.
11
 Napier JK et al documents a higher 
capacity in the differentiation between T1, T2 
and T3, of EUS compared with the CT, showing 
efficacies of 76-89% and 49-59% respectively 
on T staging.
4
 However, the EUS presents some 
limitations, these being more evident in lesions 
locally more advanced. These are not only due 
to the loss of definition that occurs when there is 
local compression, but also to the impossibility 
of progression of the probe in case of stenosis 
lesions.
10
 
In relation to CT, this exam stands out for its 
easy way to be accessed, as well as the 
usefulness in establishing invasion of adjacent 
structures by the tumour, showing specificity in 
the determination of mediastinum invasion 
around 100%.
12
  
In this study, results obtained by CT and EUS 
were compared with pathological results, aiming 
to analyze the accuracy of these exams. Only, 
for EUS, significant results were found 
(p=0.009), the number of sub and overstaging 
were higher for CT compared with EUS.  
A sub-staging in 25% (n=7) of cases staged by 
CT and 14.3% (n=4) staged by EUS, were 
observed as well as an overstaging of 39.2% 
(n=11) and 21.4% (n=6), when using the CT and 
EUS, respectively. To exclude that overstaging 
cases were due to a downstaging of primary 
therapeutic effect, patients submitted to primary 
therapy were analysed and we concluded that 
only in one case (the same for CT and EUS) it 
was not possible to exclude the effect of primary 
therapy downstaging, being the remaining cases, 
clearly, overstaging cases. It was also found that 
all cases classified as T4 by CT, (7.1%, n=2), 
were overstaging cases. This result, can be 
explained by loss of definition of the fat 
between the primary tumour and adjacent 
structures, which seems to occur in locally 
advanced tumours.
4
 This result has clear impact 
on therapeutic approach decision, if this 
decision is taken only based on CT preoperative 
results. 
In this study, the sensitivity values calculated 
for EUS were clearly superior to CT, for T1, T2 
and T3, in particular, 62.5% (95% CI, 0-40.96), 
50% (95% CI, 11.8-88.2) and 71.4% (95% CI, 
41.9-91.6), respectively. Jin Woong Cho,
13
 
presents values of 81.6%, 81.4% and 91.4%, 
respectively, however, we cannot forget that this 
exam is operator dependent, being important to 
point out the fact that, as described in other 
studies, the sensitivity of the EUS is higher in 
more advanced stages.
14,15
 
For specificity, the documented values were also 
superior for EUS, in particular, of 95% (95% CI, 
75.1-99.9) to T1, 77.3% (95% CI,54.6-92.2) for 
T2 and 71.4% (95% CI, 41.9-91.6) to T3 
compared with 85% (95% CI, 62.1-96.8) to T1, 
68.2% (95% CI, 45.1-86.1) for T2 and 57.1% 
(95% CI, 28.9-82.3) for T3 for CT. These 
results are consistent with those described in 
other studies to the extent that present the EUS 
as being a more specific exam in definition of 
the T staging.
13
 However, EUS values are 
slightly lower than those presented by Jin Cho, 
which presents values of specificity greater than 
94%, namely 99.4% 96.3% for T1, T2 and 
94.4% for T3.
13
 
As documented in literature, effectiveness 
result, were better for EUS when compared to 
TC,
4,13,16
 although results, 35.7% (95% CI, 17.9-
53.4) and 64.3% (95% CI, 46.5-82), for CT and 
EUS respectively, were lower than those 
described, 59% for CT and 85% for EUS.
4
  
For TC and EUS, T staging, an Kw=0.11 (95% 
CI, 0-0.36) and Kw=0.51 (95% CI, 0.24-0.78) 
was observed respectively, which according to 
Fleiss, indicate a poor association in the case of 
CT and moderate in the case of EUS.
9
 These 
results reinforce, in this study, that EUS is a 
most appropriate means for T staging when 
compared with the CT, in EC. 
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Regarding N staging, significant results were 
observed for staging by EUS (p=0.016). Kw of 
0.02 (95% CI, 0-0.44) and 0.45 (95% CI, 0.13-
0.77), for TC and EUS respectively, were 
documented, that according to Fleiss indicates a 
poor agreement between the two tests.
9
 
When evaluated the sensitivity, specificity and 
effectiveness of CT in N staging, values 
obtained were 30% (95% CI, 6.67-65.25), 
72.2% (95% CI, 46.5-90.3) and 57.1% (95% CI, 
38.8-75.4), therefore, this is a better test to 
exclude than to confirm lymph node invasion. 
This finding can be explained by the fact that 
the lymph node involvement by CT is dependent 
on the size of the ganglion, lacking sensitivity in 
situations where the ganglion is increased by 
inflammatory or other reasons.
17
 The results 
obtained are in agreement with studies already 
published, presenting values of sensitivity, 
specificity and effectiveness for the CT of 29%, 
60-80% and 58%, respectively.
4,18 
Regarding the EUS, sensitivity results for N 
staging, was 90% (95% CI, 55.5-99.7), higher 
than observed in literature, that refers values 
between 68-73%.
19
 Specificity results observed, 
61.1% (95% CI, 35.7-82.7), were lower than the 
documented by Sequeiros E, 79%, and slightly 
lower than the values documented for CT, 
which seems to be a better method for exclusion 
of lymph node involvement.
18
  Effectiveness 
values, 71.4% (95% CI, 54.6-88.1), matches 
with that described by other studies, namely 
Kyle Napier, which presents values of efficiency 
of 72%.  
Superior sensitivity and effectiveness results of 
EUS in N staging, were documented, although, 
as documented in literature this results can be 
improved by the use of endoscopic ultrasound 
guided aspiration biopsy, allowing an increase 
from 85% to 97% of sensitivity and from 85% 
to 96% of specificity.
16
However it is a method 
not yet commonly used, being held in reserve 
for cases in which the level of suspicion of 
ganglionic involvement is high. 
5. CONCLUSION 
Preoperative staging is the factor with the 
greatest impact on EC patient, being decisive in 
selection individualized therapeutic approach.  
Currently there are several exams available for 
preoperative staging of EC, being CT and EUS 
the most frequently used.  
EUS staging accuracy, compared to CT, 
presents a better effectiveness, sensitivity and 
specificity, for T staging. A better specificity 
and effectiveness for T1 and a greater sensitivity 
for T3, were observed. Also, for N staging, EUS 
presents better sensitivity and effectivity results. 
On the other hand, CT offers a better specificity, 
that is, it seems to be a better test to exclude 
lymph node invasion.  
We conclude that to the current knowledge, 
despite the best results for the EUS in local 
staging, CT has a place in local and distant 
staging, so EUS and CT must be considered as 
complementary and not as competitors in EC 
staging. 
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